Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.
Menu

AC Immune S.A. (ACIU)

AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch Watch
Help
Go To:
AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764 GlobeNewswire - Thu Aug 20, 6:00AM CDT

AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764

ACIU : 2.64 (-0.38%)
AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD) GlobeNewswire - Tue Aug 11, 6:00AM CDT

AC Immune receives Fast Track designation and IND clearance from the FDA for anti-alpha-synuclein active immunotherapy to treat early Parkinson's disease...

ACIU : 2.64 (-0.38%)
AC Immune: Q2 Earnings Snapshot AP - Wed Aug 5, 7:00AM CDT

AC Immune: Q2 Earnings Snapshot

ACIU : 2.64 (-0.38%)
AC Immune First Half 2026 Financial and Corporate Update GlobeNewswire - Wed Aug 5, 6:00AM CDT

AC Immune First Half 2026 Financial and Corporate Update

ACIU : 2.64 (-0.38%)
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease GlobeNewswire - Tue Jun 30, 6:00AM CDT

AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease ACI-24 anti-Abeta active immunotherapy...

ACIU : 2.64 (-0.38%)
AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS GlobeNewswire - Fri May 22, 6:00AM CDT

AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS Presentation at 2026 TDP43 Summit shows...

ACIU : 2.64 (-0.38%)
AC Immune: Q1 Earnings Snapshot AP - Thu Apr 30, 6:13AM CDT

AC Immune: Q1 Earnings Snapshot

ACIU : 2.64 (-0.38%)
AC Immune First Quarter 2026 Financial and Corporate Updates GlobeNewswire - Thu Apr 30, 6:05AM CDT

AC Immune First Quarter 2026 Financial and Corporate Updates Dosed first subjects in Phase 1 trial of brain-penetrant small molecule NLRP3 inhibitor...

ACIU : 2.64 (-0.38%)
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease GlobeNewswire - Thu Apr 30, 6:00AM CDT

AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease Treatment of first...

ACIU : 2.64 (-0.38%)
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly GlobeNewswire - Tue Apr 7, 6:00AM CDT

AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly Amended agreement reflects growing excitement in the field...

ACIU : 2.64 (-0.38%)

Barchart Exclusives

Nvidia Can Clearly Afford a Bigger Dividend. Why Its Payout Hasn’t Grown. Barchart - Mon Aug 31, 6:30PM CDT
Nvidia left its quarterly dividend unchanged at $0.25 after reporting Q2 revenue of $96.2 billion, even though the company clearly has the cash to pay more. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.